Place: Cambridge
Biography:
Kuan-Chun Huang is a Research Director at H3 Biomedicine Inc. in Cambridge, Massachusetts. He is also a Doctor of Philosophy. He is known for his work in the field of biomedicine and has been cited over 1,400 times. He has also published two works in the field of engineering applications and lexical semantic similarity. He is also a member of the American Association for Cancer Research and has published a paper on the use of E7766, a novel STING agonist, as a potent immunotherapy in BCG-insensitive non-muscle invasive bladder cancer models. He is also a member of the ORCID and has an ID of 0000-0002-4915-5017. He is also a co-author of a paper on Tunable Spinel Structure Phosphors: Dynamic Change in Advanced Optical Materials. He is also a member of the team at ARCE Therapeutics, Inc. He is also a member of LinkedIn and has a profile under the name Kuan-Chun Huang. He is also a co-author of a paper on Hidden Structural Evolution and Bond Valence Control in Cr 3+ -doped phosphors. He is also a member of OCRA and has a bio on their website. He is also a member of the team at Cycu.edu.tw and has a page on their website.